aimed to quantify the degree of contracture in 8 key muscles at a chronic stage after the lesion. Methods Four independent raters assessed 18 adults with chronic hemiparesis (age: 50 AE 14, mean AE SD; time since lesion 5.3 AE 2.4 years) treated with guided self-rehabilitation contracts (GSC) [1], using the 5-step clinical assessment [2] previously described, of which step 2 evaluates passive range of motion (angle of arrest at slow speed, X V1 ) and step 3 measures the angle of catch at fast speed (X V3 ). Data from the 4 investigators were averaged. Coefficients of shortening (C SH = (X N À X V1 )/X N ; X N , normal expected amplitude) and of spasticity (C SP = (X V1 À X V3 )/X V1 ) were derived. Muscles assessed were shoulder extensors (SE), elbow flexors (EF), wrist flexors (WF), finger flexors (FF), gluteus maximus (GM), rectus femoris (RF), soleus (SO) and gastrocnemius muscles (GM). Background Late recovery after a first ischemic stroke is highly variable and its predictors are unknown. The present study aims at determining whether MRI data obtained one to four months after a first ischemic stroke help to predict clinical evolution up to 2 years. Methods Patients included in the PERFORM MRI study, an ancillary study of the PERFORM randomized control trial of terutroban against aspirin in secondary prevention of vascular ischemic events were selected. Mixed-effect regression modelling was used to test whether MRI data obtained one to four months after a first ischemic stroke ameliorate the prediction of further recovery, up to 2 years, compared to clinical data alone. Outcomes to predict were disability (modified Rankin Scale [mRS] and NIH Stroke Scale [NIHSS]) and cognition (MMSE, Isaac's Set Test [IST] and Zazzo's Cancellation Test [ZCT]). MRI markers were designed as the total lesion load on FLAIR (FLAIR_vol) and brain volume
MRI ameliorates the prediction of further clinical evolution even months after ischemic stroke Background Late recovery after a first ischemic stroke is highly variable and its predictors are unknown. The present study aims at determining whether MRI data obtained one to four months after a first ischemic stroke help to predict clinical evolution up to 2 years. Methods Patients included in the PERFORM MRI study, an ancillary study of the PERFORM randomized control trial of terutroban against aspirin in secondary prevention of vascular ischemic events were selected. Mixed-effect regression modelling was used to test whether MRI data obtained one to four months after a first ischemic stroke ameliorate the prediction of further recovery, up to 2 years, compared to clinical data alone. Outcomes to predict were disability (modified Rankin Scale [mRS] and NIH Stroke Scale [NIHSS] ) and cognition (MMSE, Isaac's Set Test [IST] and Zazzo's Cancellation Test [ZCT] ). MRI markers were designed as the total lesion load on FLAIR (FLAIR_vol) and brain volume (brain parenchymal fraction [BPF]) on T1, both normalized to intracranial cavity volume. Age, gender, level of education and initial value of the outcome to predict were systematically entered as covariates in predictive models based on clinical data alone. FLAIR_Vol, BPF and microbleed number were added to those variables in predictive models based on clinical and imaging data. Predictive ability of both types of models were compared. Findings Five hundred and ninety-two patients of mean age 67.3 AE 7.8 years were included. Models based on clinical and MRI data were significantly better predictors of mRS, MMSE, IST and ZCT, compared to models based on clinical data alone. Interpretation MRI data that can be easily extracted from routine sequences help to predict further recovery even months after a first ischemic stroke. The use of MRI in this context may help to select patients for which rehabilitation will be the most beneficial. Keywords 
